Celularity Inc (CELU): Nasdaq/NYSE listing notice — Celularity receives Nasdaq delisting notice for late Q3 2024 10-Q filing

Celularity Inc

Failed to file Q3 2024 10-Q by Nov 19 extension; Nasdaq issued non-compliance notice on Nov 21, 2024.
No immediate effect on CELU/CELUW trading; must submit compliance plan by Jan 20, 2025.
If plan accepted, compliance deadline extended to May 13, 2025. No assurance of regaining compliance.
Delay attributed to incomplete preparation of financial statements for Q3 2024.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Celularity Inc received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

November 21, 2024, the Company informed the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) that it failed to timely file its Q3 2024 Form 10-Q within the extension period provided by Rule 12b-25 because the Company had not yet completed the preparation of the financial statements. On November 21, 2024, Nasdaq provided formal notice to the Company that as a result of the Company’s failure to timely file its Q3 2024 10-Q, it no longer complied with the continued listing requirements under the timely filing criteria outlined in Nasdaq Listing Rule 5250(c)(1). Nasdaq’s

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Celularity Inc filing history →

Source: SEC EDGAR

accession 0001493152-24-048082

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.